ListarDAAPC-Artículos, capítulos... por tema "Bladder cancer"

Mostrando ítems 1-2 de 2

    • A Multiplex Test Assessing MiR663ame and VIMme in Urine Accurately Discriminates Bladder Cancer from Inflammatory Conditions 

      Monteiro-Reis, Sara; Blanca, Ana; Tedim-Moreira, Joana; Carneiro, Isa; Montezuma, Diana; Monteiro, Paula; Oliveira, Jorge; Antunes, Luís; Henrique, Rui; López-Beltrán, Antonio; Jerónimo, Carmen (MDPI, 2020)
      Bladder cancer (BlCa) is a common malignancy with significant morbidity and mortality. Current diagnostic methods are invasive and costly, showing the need for newer biomarkers. Although several epigenetic-based biomarkers ...

    • Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer 

      López-Beltrán, Antonio; Cimadamore, Alessia; Blanca, Ana; Massari, Francesco; Vau, Nuno; Scarpelli, Marina; Cheng, Liang; Montironi, Rodolfo (MDPI, 2021)
      A number of immune checkpoint inhibitors (ICIs) have been approved as first-line therapy in case of cisplatin-ineligible patients or as second-line therapy for patients with metastatic urothelial carcinoma (mUC) of the ...